Summary:
This is a 52 week randomized, double blind, 2 arm, parallel group trial comparing the study product to a fixed dose dual combination therapy.
Qualified Participants Must:
• Be over 40 years of age
•
Have a COPD diagnosis for at least 12 months
•
Meet eligibility requirements
Qualified Participants May Receive:
All study procedures and testing at no charge, including pulmonary function tests, labs, and ECGs.
Study medications (including rescue medication) at no charge
Stipends are paid to participants for every completed clinic visit